Tamara Kolev, MD
Gynecology · New York, NYNPI 1598928756
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $64,175 of the $91,099 with a category attached, or 70.4%. AbbVie accounts for 95.4% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2019 at $45,534 and has fallen 96.5% since, to $1,588 in 2025. Among gynecology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 115 payments — averaging $792.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$87K
- Gynesonics, Inc.$2K
- Intuitive Surgical$2K
- Covidien LP$500
- Medtronic$450
What the payments were for
- Consulting fees$8,75610%
- Speaking & faculty fees$64,17570%
- Travel & lodging$14,04415%
- Food & beverage$4,0794%
- Education$440%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 98 | $86,868 |
| Gynesonics, Inc. | 4 | $1,645 |
| Intuitive Surgical | 11 | $1,636 |
| Covidien LP | 1 | $500 |
| Medtronic | 1 | $450 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Orilissa$66,517
- ORIAHNN$18,522
- SONATA SONOGRAPHY-GUIDED TRANSCERVICAL FIBROID ABLATION SYSTEM$1,645
- Da Vinci Surgical System$1,446
- LigaSure$500
How this compares
$91,099 in reported general payments places this provider in the 95th percentile of 240 gynecology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 31 | $2,563 |
| YuvafemEstradiol | 13 | $1,746 |
| ValacyclovirValacyclovir Hcl | 11 | $363 |
Paid to pharmacies, not to this prescriber.
Other gynecology in New York
- Arnold AdvinculaNew York$2.1M
- Charles Ascher-WalshNew York$43K
- Paula CastanoNew York$31K
- Christopher EswarNew York$25K
- Neena AgarwalaNew York$17K
- Tara AllmenNew York$8K
- Jorge VenegasNew York$7K
- Molly McBrideNew York$7K
- Connie LiuNew York$7K
- Owen DavisNew York$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.